Following up on European clearance last December, Boston Scientific won regulatory approval in the U.S. for its Precision Spectra spinal cord stimulator for pain management. The device features 32 contacts, each with a dedicated power source, for greater control over the application of current to the spinal cord.
The system comes with its own Illumina 3D software that calculates electric characteristics of the anatomy around the electrodes and allows for intuitive programming of the implant with less guesswork.
From Boston Sci:
The Precision Spectra System features Illumina 3D software designed to improve control of the stimulation field. The software is based on a proprietary computer model that takes into account 3D anatomical structures, including the conductivity of the spinal cord and surrounding tissue. The physician simply selects a desired location on the spinal cord and the programming software creates a customized stimulation field to mask the patient’s pain.
“The Precision Spectra System represents a paradigm shift in spinal cord stimulation,” said Giancarlo Barolat, M.D., medical director of Barolat Neuroscience in Denver. “The Illumina 3D Software is the first SCS programming technology based on advanced anatomical and scientific principles. When combined with 32 contacts and four lead ports—twice that of any other SCS system—the Precision Spectra technology gives physicians more flexibility to customize therapy for patients.”
Flashback: Boston Sci’s New 32 Contact Spinal Cord Stimulator Approved in Europe
Press release: Boston Scientific Launches Precision Spectra™ Spinal Cord Stimulator System In The United States…
